ARCHIVES

Group Chairman Balk At Board’s Recommendations

This article is from The Cancer Letter archive.

Vol. 06 No. 07 | February 15, 1980

Download PDF Visit The Full Archive

Related Articles

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

NCI-Approved Clinical Trials

June 24, 2005

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

Cancer Meetings Listed For Next Three Months

September 20, 1996

Final Issue of ‘76

December 10, 1976

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001